The Cure For Profits: How Poly Medicure Yielded 2166% Returns

If you had ₹1 lakh invested in Poly Medicure in September 2012, you could have had ₹26 lakhs today! This multibagger gave its investors ₹21,66,000 in returns and ₹3,63,630 in dividends in 10 years. Here’s a quick peek at the company.

🩺 Stock Name: Poly Medicure Ltd.
🩺 NSE: $POLYMED

💡 About the Company
Poly Medicure is a medical device manufacturer dedicated to providing premium healthcare. Innovation is an integral part of its story as it is committed to offering safe and high-quality products to the Medical fraternity and patients, thus ensuring care at all levels.
It specialises in making devices for medical branches like:
💉 Oncology
💉 Infusion Therapy
💉 Dialysis
💉 Respiratory Care
💉 Blood Management System
💉 Anaesthesia
💉 COVID Care

🌍 Global Presence
It faces stiff competition in the global market from Baxter, Becton Dickinson, Boston Scientific and others. It exports to over 110 countries and has grown exponentially in the European subcontinent. It has a pan-India distribution network with over 260 distributors and a presence in over 5,000 private & government hospitals and nursing homes. It also faces stiff competition in the domestic market from unorganised players.

📄 R&D and Patents
It has an R&D facility in Faridabad with over 300 patents to its name and 190 patents pending approval. The company is the top exporter of plastic medical disposables. It has a portfolio of over 130 stock-keeping units (SKUs) of disposable medical devices across 9 different product verticals.

It is committed to being a global manufacturer & supplier of medical devices by actively pursuing excellence and customer satisfaction through effective quality management systems, innovation & cost-effective technologies and continual improvements.

Stock Value 💰
On September 8, 2012, the shares of the company were trading at ₹37.95, while they were priced at ₹860.3 as of September 7, 2022.